Radiotherapy and the gut microbiome: facts and fiction
暂无分享,去创建一个
[1] J. Petrosino,et al. Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer , 2021 .
[2] W. Makarewicz,et al. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics , 2020, Gut microbes.
[3] Saijun Fan,et al. Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein , 2020, Microbiome.
[4] B. Subhadra,et al. Colorectal Cancer and Probiotics: Are Bugs Really Drugs? , 2020, Cancers.
[5] J. Park,et al. Gut microbiome composition is associated with a pathologic response after preoperative chemoradiation in rectal cancer patients. , 2020, International journal of radiation oncology, biology, physics.
[6] J. Bou Khalil,et al. Full-repertoire comparison of the microscopic objects composing the human gut microbiome with sequenced and cultured communities , 2020, Journal of Microbiology.
[7] Bota Cui,et al. Fecal microbiota transplantation: A promising treatment for radiation enteritis? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] J. O’Sullivan,et al. Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers , 2020, Nature Reviews Gastroenterology & Hepatology.
[9] J. Petrosino,et al. Microbial Diversity and Composition is Associated with Patient-Reported Toxicity during Chemo radiation Therapy for Cervical Cancer. , 2020, International journal of radiation oncology, biology, physics.
[10] S. Chan. Microbiome and cancer treatment: Are we ready to apply in clinics? , 2020, Progress in molecular biology and translational science.
[11] F. Bushman,et al. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. , 2019, The Journal of clinical investigation.
[12] A. Santerre,et al. Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis , 2019, Probiotics and Antimicrobial Proteins.
[13] Wantong Song,et al. Nanotechnology intervention of the microbiome for cancer therapy , 2019, Nature Nanotechnology.
[14] R. Weigel,et al. Randomized Trial of Perioperative Probiotics among Patients Undergoing Major Abdominal Operation. , 2019, Journal of the American College of Surgeons.
[15] A. Russo,et al. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. , 2019, Critical reviews in oncology/hematology.
[16] Fatemeh Zununi Vahed,et al. The impact of tumor and gut microbiotas on cancer therapy; Beneficial or detrimental? , 2019, Life sciences.
[17] Jeong-Seok Nam,et al. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance , 2019, Journal of Experimental & Clinical Cancer Research.
[18] M. Liss,et al. The Microbiome and Prostate Cancer Risk , 2019, Current Urology Reports.
[19] E. Jacobs,et al. The Association between Prebiotic Fiber Supplement Use and Colorectal Cancer Risk and Mortality in the Women's Health Initiative , 2019, Cancer Epidemiology, Biomarkers & Prevention.
[20] D. Lobo,et al. Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery , 2019, Annals of surgery.
[21] R. Sidman,et al. Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer , 2019, Proceedings of the National Academy of Sciences.
[22] Christine B. Peterson,et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes , 2019, Cell.
[23] A. Linge,et al. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed , 2019, Autophagy.
[24] I. Kareva. Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review , 2019, Stem cells.
[25] Kevin S. Bonham,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[26] Xu Zhang,et al. Perspective and Guidelines for Metaproteomics in Microbiome Studies. , 2019, Journal of proteome research.
[27] H. Le,et al. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis , 2019, Expert review of gastroenterology & hepatology.
[28] Paul Theodor Pyl,et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.
[29] S. Umar,et al. The Duplex Interaction of Microbiome with Chemoradiation and Immunotherapy: Potential Implications for Colorectal Cancer , 2019, Current Colorectal Cancer Reports.
[30] Tal Danino,et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity , 2019, Nature Medicine.
[31] B. Helmink,et al. The microbiome, cancer, and cancer therapy , 2019, Nature Medicine.
[32] A. Abdollahi,et al. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity , 2019, Clinical Cancer Research.
[33] Harris H. Wang,et al. Metagenomic engineering of the mammalian gut microbiome in situ , 2018, Nature Methods.
[34] S. Gately. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients. , 2019, Cancer treatment and research.
[35] J. Younes,et al. Pre-, pro- and synbiotics in cancer prevention and treatment—a review of basic and clinical research , 2018, Ecancermedicalscience.
[36] S. Haase,et al. Impacts of microbiome metabolites on immune regulation and autoimmunity , 2018, Immunology.
[37] P. Saris,et al. Innovative approaches to nisin production , 2018, Applied Microbiology and Biotechnology.
[38] Jean Paul Thiery,et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention , 2018, Nature Biomedical Engineering.
[39] J. Ravel,et al. Improving regulation of microbiota transplants , 2017, Science.
[40] Donna Neuberg,et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer , 2017, Science.
[41] Luis Pedro Coelho,et al. Subspecies in the global human gut microbiome , 2017, Molecular systems biology.
[42] P. Tso,et al. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease , 2017, Front. Immunol..
[43] Fangfang Guo,et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.
[44] David A. Drew,et al. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue , 2017, JAMA oncology.
[45] Glenn R. Gibson,et al. The International Scientific Association for Probiotics and Prebiotics ( ISAPP ) consensus statement on the definition and scope of prebiotics , 2018 .
[46] Y. Shu,et al. Probiotics for prevention of radiation-induced diarrhea: A meta-analysis of randomized controlled trials , 2017, PloS one.
[47] Bangmao Wang,et al. Secondary bile acid‐induced dysbiosis promotes intestinal carcinogenesis , 2017, International journal of cancer.
[48] Soumen Roy,et al. Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.
[49] Y. Kashi,et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction , 2017, Gut.
[50] C. Danjoux,et al. Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).
[51] Ian D. Wilson,et al. Gut microbiota modulation of chemotherapy efficacy and toxicity , 2017, Nature Reviews Gastroenterology &Hepatology.
[52] R. Sleator,et al. Engineered Probiotics: Applications and Biological Containment. , 2017, Annual review of food science and technology.
[53] Junling Zhang,et al. Faecal microbiota transplantation protects against radiation‐induced toxicity , 2017, EMBO molecular medicine.
[54] A. Freifeld,et al. Clostridium difficile-Associated Diarrhea in the Oncology Patient. , 2017, Journal of oncology practice.
[55] F. Cappello,et al. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping. , 2017, Journal of biological regulators and homeostatic agents.
[56] V. Azevedo,et al. Anti‐cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL‐10 in a colorectal cancer mouse model , 2017, International immunopharmacology.
[57] Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells , 2016, BMC Cancer.
[58] B. Deng,et al. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota , 2016, Oncotarget.
[59] Saijun Fan,et al. Circadian Rhythm Shapes the Gut Microbiota Affecting Host Radiosensitivity , 2016, International journal of molecular sciences.
[60] M. Maeda,et al. Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell. , 2016, Biochemical and biophysical research communications.
[61] Tytus D. Mak,et al. An Integrated Multi-Omic Approach to Assess Radiation Injury on the Host-Microbiome Axis , 2016, Radiation Research.
[62] Muhammad Anis Uddin Nasir,et al. Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats , 2016, Nutrients.
[63] R. Yantiss,et al. Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden , 2016, Cancer Prevention Research.
[64] W. El-Deiry,et al. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation. , 2016, Cancer research.
[65] M. Hutchinson,et al. Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms , 2016, Molecular Cancer Therapeutics.
[66] T. Preston,et al. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.
[67] B. Krebs. Prebiotic and Synbiotic Treatment before Colorectal Surgery--Randomised Double Blind Trial. , 2016, Collegium antropologicum.
[68] G. Jan,et al. The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer , 2016, Oncotarget.
[69] P. Langella,et al. Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer , 2016, Journal of Gastroenterology.
[70] F. Ginhoux,et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota , 2015, Science.
[71] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[72] P. Cotter,et al. Faculty Opinions recommendation of Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. , 2015 .
[73] Pavlos Bousounis,et al. Bacteriocin production augments niche competition by enterococci in the mammalian GI tract , 2015, Nature.
[74] Glenn Gibson,et al. Impact of palm date consumption on microbiota growth and large intestinal health: a randomised, controlled, cross-over, human intervention study , 2015, British Journal of Nutrition.
[75] Jun Yu,et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment , 2015, Oncotarget.
[76] Katie Kingwell. Bacteriophage therapies re-enter clinical trials , 2015, Nature Reviews Drug Discovery.
[77] Kavita R Pandey,et al. Probiotics, prebiotics and synbiotics- a review , 2015, Journal of Food Science and Technology.
[78] G. Young,et al. Butyrylated starch intake can prevent red meat-induced O6-methyl-2-deoxyguanosine adducts in human rectal tissue: a randomised clinical trial , 2015, British Journal of Nutrition.
[79] Jinu Kim,et al. High-throughput 16S rRNA gene sequencing reveals alterations of mouse intestinal microbiota after radiotherapy. , 2015, Anaerobe.
[80] T. Cheng,et al. Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study , 2015, PloS one.
[81] J. Parkhill,et al. TLR Signaling Modulates Side Effects of Anticancer Therapy in the Small Intestine , 2015, The Journal of Immunology.
[82] J. Delcour,et al. Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects. , 2015, The British journal of nutrition.
[83] N. Naud,et al. Antibiotic Suppression of Intestinal Microbiota Reduces Heme-Induced Lipoperoxidation Associated with Colon Carcinogenesis in Rats , 2015, Nutrition and cancer.
[84] David G Besselsen,et al. The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention , 2014, Inflammatory bowel diseases.
[85] R. Baskar,et al. Biological response of cancer cells to radiation treatment , 2014, Front. Mol. Biosci..
[86] A. Dagnault,et al. A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. , 2014, Clinical nutrition.
[87] E. Montassier,et al. Systematic review: the role of the gut microbiota in chemotherapy‐ or radiation‐induced gastrointestinal mucositis – current evidence and potential clinical applications , 2014, Alimentary pharmacology & therapeutics.
[88] P. Kruzliak,et al. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats. , 2014, Rejuvenation research.
[89] Bas E Dutilh,et al. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. , 2014, Omics : a journal of integrative biology.
[90] A. Molan,et al. Evaluation of the Effect of Blackcurrant Products on Gut Microbiota and on Markers of Risk for Colon Cancer in Humans , 2014, Phytotherapy research : PTR.
[91] D. Dearnaley,et al. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. , 2014, The Lancet. Oncology.
[92] S. Massart,et al. 16S rRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota During High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation , 2014, Microbial Ecology.
[93] E. Pamer,et al. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns , 2014, Mucosal Immunology.
[94] H. Kim,et al. Impact of Pelvic Radiotherapy on Gut Microbiota of Gynecological Cancer Patients Revealed by Massive Pyrosequencing , 2013, PloS one.
[95] G. Augustin,et al. A Randomized Clinical Trial of Synbiotic Treatment before Colorectal Cancer Surgery , 2013, The American surgeon.
[96] F. Marincola,et al. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment , 2013, Science.
[97] Eric Vivier,et al. The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide , 2013, Science.
[98] Gaurav Agrawal,et al. Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions , 2013, Current Gastroenterology Reports.
[99] J. Doré,et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[100] R. Jena,et al. Advances in radiotherapy , 2012, British medical journal.
[101] D. Jaffray. Image-guided radiotherapy: from current concept to future perspectives , 2012, Nature Reviews Clinical Oncology.
[102] Richard A. Moore,et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.
[103] W. Verstraete,et al. Bacterial monocultures, propionate, butyrate and H2O2 modulate the expression, secretion and structure of the fasting-induced adipose factor in gut epithelial cell lines. , 2011, Environmental microbiology.
[104] Y. Kuwahara,et al. Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy , 2011, Cell Death and Disease.
[105] Fiona A. Stewart,et al. Strategies to improve radiotherapy with targeted drugs , 2011, Nature Reviews Cancer.
[106] R. Benya,et al. Randomized Phase II Trial of Sulindac, Atorvastatin, and Prebiotic Dietary Fiber for Colorectal Cancer Chemoprevention , 2011, Cancer Prevention Research.
[107] W. Tissing,et al. The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis , 2010, PLoS pathogens.
[108] J. Alsner,et al. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[109] B. Leggett,et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. , 2009, The American journal of clinical nutrition.
[110] Alison M. Dunning,et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype , 2009, Nature Reviews Cancer.
[111] C. Manichanh,et al. The Gut Microbiota Predispose to the Pathophysiology of Acute Postradiotherapy Diarrhea , 2008, The American Journal of Gastroenterology.
[112] S. Sonis,et al. Management of oral mucositis in patients who have cancer. , 2008, Dental clinics of North America.
[113] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[114] Geoff Delaney,et al. The role of radiotherapy in cancer treatment , 2005, Cancer.
[115] J. Gordon,et al. Microbial regulation of intestinal radiosensitivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[116] L. Elting,et al. Perspectives on cancer therapy‐induced mucosal injury , 2004, Cancer.
[117] M. Karin,et al. IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium , 2004 .
[118] R. Lorenz,et al. TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[119] S. Cohn,et al. Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. , 2000, Gastroenterology.
[120] Bentzen,et al. Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.
[121] M. Lederman. Advances in radiotherapy. , 1970, The Practitioner.